These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 30173649)

  • 1. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
    Li W; Sun X
    Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhang Y; Ji W; He L; Chen Y; Ding X; Sun Y; Hu S; Yang H; Huang W; Zhang Y; Liu F; Xia L
    Theranostics; 2018; 8(6):1690-1705. PubMed ID: 29556350
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy.
    Yu T; Tang B; Sun X
    Yonsei Med J; 2017 May; 58(3):489-496. PubMed ID: 28332352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
    Philip B; Ito K; Moreno-Sánchez R; Ralph SJ
    Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton channels and exchangers in cancer.
    Spugnini EP; Sonveaux P; Stock C; Perez-Sayans M; De Milito A; Avnet S; Garcìa AG; Harguindey S; Fais S
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2715-26. PubMed ID: 25449995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia Boosts Aerobic Glycolysis in Carcinoma: A Complex Process for Tumour Development.
    Zheng X; Fan H; Liu Y; Wei Z; Li X; Wang A; Chen W; Lu Y
    Curr Mol Pharmacol; 2022; 15(3):487-501. PubMed ID: 34382521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimuli-responsive nanoparticles for targeting the tumor microenvironment.
    Du J; Lane LA; Nie S
    J Control Release; 2015 Dec; 219():205-214. PubMed ID: 26341694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemic/hypoxic condition in vitro mimicking the tumor microenvironment markedly reduced the efficacy of anticancer drugs.
    Onozuka H; Tsuchihara K; Esumi H
    Cancer Sci; 2011 May; 102(5):975-82. PubMed ID: 21255190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-responsive nanoparticles for tumor-targeted drug delivery.
    Li Y; Jeon J; Park JH
    Cancer Lett; 2020 Oct; 490():31-43. PubMed ID: 32585414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.
    Wouters A; Boeckx C; Vermorken JB; Van den Weyngaert D; Peeters M; Lardon F
    Curr Pharm Des; 2013; 19(5):907-17. PubMed ID: 22973959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
    Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
    Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting hypoxic response for cancer therapy.
    Paolicchi E; Gemignani F; Krstic-Demonacos M; Dedhar S; Mutti L; Landi S
    Oncotarget; 2016 Mar; 7(12):13464-78. PubMed ID: 26859576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of plant-derived bioactive compounds to target cancer stem cells and modulate tumor microenvironment.
    Pistollato F; Giampieri F; Battino M
    Food Chem Toxicol; 2015 Jan; 75():58-70. PubMed ID: 25445513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-sensitive drug-delivery systems for tumor targeting.
    He X; Li J; An S; Jiang C
    Ther Deliv; 2013 Dec; 4(12):1499-510. PubMed ID: 24304248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual targeting of hypoxic and acidic tumor environments with a cobalt(III) chaperone complex.
    Yamamoto N; Renfrew AK; Kim BJ; Bryce NS; Hambley TW
    J Med Chem; 2012 Dec; 55(24):11013-21. PubMed ID: 23199008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.
    Wigerup C; Påhlman S; Bexell D
    Pharmacol Ther; 2016 Aug; 164():152-69. PubMed ID: 27139518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.